Day: April 29, 2020

SAN DIEGO, April 29, 2020 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment of cancer, today announced that it will report first quarter 2020 financial results after the close of U.S. financial markets on Monday, May 4, 2020. Kura’s management will host a webcast and conference call at 4:30 p.m. ET / 1:30 p.m. PT that day to discuss the financial results and provide a corporate update.The live call may be accessed by dialing 877-516-3514 for domestic callers and 281-973-6129 for international callers and entering the conference code: 2085246. A live webcast and archive of the call will be available online from the investor relations section of the company website at www.kuraoncology.com.                                                                                             About...

SOUTH ORANGE, NJ, April 29, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will file its first quarter 2020 financial results on Wednesday, May 6, 2020 and will host a conference call that same day at 4:30 PM ET, during which management will discuss the company’s financial results and provide a general business overview.Participants may dial into the following number to access the call: 1-888-220-8474. International callers may use 1-323-794-2588. Please ask to be joined into the Nephros conference call. A replay of the call can be accessed until May 20, 2020 at 1-844-512-2921 or 1-412-317-6671 for international...

JOHNS CREEK, Ga. , April 29, 2020 (GLOBE NEWSWIRE) — Saia, Inc. (Nasdaq: SAIA), a leading transportation provider offering multi-regional less-than-truckload (LTL), non-asset truckload, expedited and logistics services, today reported first quarter 2020 financial results.  Diluted earnings per share in the quarter were $1.06 compared to $0.85 in the first quarter of 2019.Highlights from the first quarter operating results were as follows:First Quarter 2020 Compared to First Quarter 2019 ResultsRevenue was $446.4 million, an 8.7% increaseOperating income was $38.8 million, a 35.4% increaseOperating ratio of 91.3 compared to 93.0LTL shipments per workday rose 2.3%LTL tonnage per workday increased by 4.0%LTL revenue per hundredweight increased 3.1%LTL revenue per shipment rose 4.9% to $241.61“First quarter results were marked by shipment...

CAMBRIDGE, Mass., April 29, 2020 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today announced multiple data presentations at the American Society of Gene and Cell Therapy (ASGCT) 23rd Annual Meeting taking place virtually on May 12-15, 2020.The ASGCT abstracts are now available at https://www.asgct.org/.Details for the oral presentations are as follows:Title: Development of AAV-based RNAi Therapeutics for Huntington’s DiseaseSession: Scientific SymposiumDate/time: May 12, 2020, 9:18-9:45 a.m. ETTitle: Engineering Viral Protein Ratios to Impact AAV PotencySession: AAV Vectors – Clinical Studies IIDate/time: May 13, 2020, 5:00-5:15 p.m. ETTitle: Lac Repressor Inducible Control of AAV Capsid...

STRASBURG, Va., April 29, 2020 (GLOBE NEWSWIRE) — First National Corporation (the “Company” or “First National”) (NASDAQ: FXNC) reported unaudited consolidated net income of $1.7 million, or $0.34 per diluted share, for the first quarter of 2020, which resulted in a return on average assets of 0.85% and a return on average equity of 8.72%. This was a $556 thousand, or 25%, decrease compared to net income for the first quarter of 2019, which totaled $2.3 million or $0.46 per diluted share, and a return on average assets of 1.21% and a return on average equity of 13.47%.Highlights for the first quarter of 2020:Provision for loan losses totaled $900 thousand, compared to no provision in Q1 2019Cash and unencumbered securities totaled $133.4 million, or 16% of assetsNonperforming assets decreased to 0.19% of assetsLoans increased $30.8...

NEW YORK, April 29, 2020 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Wednesday, May 6, 2020. Participating on the call will be Dr. Phil Gomez, Chief Executive Officer, Daniel Luckshire, Chief Financial Officer, and Dr. Dennis Hruby, Chief Scientific Officer.A live webcast of the call will be available on the Company’s website at www.siga.com under the ‘Events & Presentations’ tab in the Investor Relations section, or by clicking here. Participants may also access the call, by dialing (877) 407-6184 for domestic callers or (201) 389-0877 for international callers. Please log in approximately...

The following resolutions have been adopted at the Annual General Meeting of Shareholders of Panevezio statybos trestas AB taken place on 29 April 2020:1.      The conclusions of the audit regarding the Financial Statements and Annual Report of the Company for the year 2019.The shareholders have familiarized themselves with the information.2.      The Annual Report of the Company for the year 2019.The shareholders have familiarized themselves with the information.3.      Approval of the set of Financial Statements of the Company for the year 2019.The Consolidated and Individual Financial Statements of Panevezio statybos trestas AB for the year 2019, which have been prepared in accordance with the International Financial Reporting Standards as adopted by the European Union and are submitted together with the independent auditor’s opinion,...

 2020 m. balandžio 29 d. įvykusio AB „Panevėžio statybos trestas“ eilinio akcininkų susirinkimo priimti nutarimai: 1. Audito išvados dėl 2019 m. Bendrovės finansinės atskaitomybės ir metinio pranešimo.Su informacija akcininkai susipažino.2. Bendrovės 2019 m. metinis pranešimas.Su informacija akcininkai susipažino.3. Bendrovės 2019 metų finansinių ataskaitų rinkinio tvirtinimas.Patvirtintos 2019 metų AB “Panevėžio statybos trestas” metinės konsoliduotos  ir atskiros finansinės ataskaitos, parengtos pagal Tarptautinius finansinės atskaitomybės standartus, priimtus taikyti Europos Sąjungoje, pateikiamos kartu su nepriklausomo auditoriaus išvada.4. Bendrovės pelno (nuostolių) paskirstymas.Patvirtintas AB „Panevėžio statybos trestas“ pelno (nuostolių) paskirstymas:Ankstesnių finansinių metų nepaskirstytasis pelnas (nuostoliai) ataskaitinių...

Copenhagen, April 29, 2020 (GLOBE NEWSWIRE) —Opdateret prospekt for ovennævnte forening offentliggøres dags dato.Prospektet er opdateret med regnskabstal fra årsrapporten 2019.Dokumentet kan downloades fra www.valueinvest.dk eller rekvireres ved henvendelse til BI Management A/S, Sundkrogsgade 7, 2100 København Ø, tlf. 77 30 90 00.Vedhæftede filerProspekt VAI 2020.04.29 cleanVedtægter ValueInvest – 2019.08.21 inkl. tillæg A 2017.03.28 clean

2020-04-29PRESSRELEASE Rättelse: Årsredovisning 2019 är nu publiceradRättelsen avser felaktig hänvisning till EU:s marknadsmissbruksförordning.Arcoma publicerar idag sin årsredovisning för verksamhetsåret 2019 på bolagets hemsida www.arcoma.se/about-us/investors. Tryckt exemplar kan beställas via service@arcoma.se.Om ArcomaArcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalitet och avancerad teknik. Arcomas produkter erbjuder den senaste digitala bildtekniken kombinerat med tekniskt avancerade rörliga positioneringssystem, vilket tillsammans med ergonomisk skandinavisk design, erbjuder kunden kompletta, konfigurerbara och funktionella digitala röntgensystem. Bolagets produkter säljs via återförsäljare samt via OEM-kunder och det finns idag över 3 500 av Arcomas röntgensystem...